Trisalus Life Sciences Inc (TLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 4,612 | 2,984 | 8,475 | 3,923 | 0 |
| Cost of Goods | 772 | 662 | 1,557 | 701 | N/A |
| Gross Profit | 3,840 | 2,322 | 6,918 | 3,222 | N/A |
| Operating Expenses | 16,046 | 13,105 | 34,845 | 12,034 | 288 |
| Operating Income | -11,434 | -10,121 | -27,370 | -8,111 | -288 |
| Interest Expense | 4 | 5 | 0 | 0 | 0 |
| Other Income | -2,523 | 1,853 | -16,966 | 18 | 2,703 |
| Pre-tax Income | -13,961 | -8,273 | -44,336 | -8,093 | 2,414 |
| Income Tax | 13 | -5 | -19 | N/A | 28 |
| Net Income Continuous | -13,974 | -8,268 | -44,317 | -8,093 | 2,386 |
| Net Income | $-13,974 | $-8,268 | $-44,317 | $-8,093 | $2,386 |
| EPS Basic Total Ops | -35.84 | -0.57 | -135.77 | -25.95 | 0.08 |
| EPS Basic Continuous Ops | -31.33 | -0.51 | -127.10 | -25.95 | 0.38 |
| EPS Diluted Total Ops | -35.84 | -0.57 | -135.77 | -25.95 | 0.08 |
| EPS Diluted Continuous Ops | -31.33 | -0.51 | -127.10 | -25.95 | 0.38 |
| EBITDA(a) | $-11,284 | $-9,937 | $-27,424 | $-8,111 | $-288 |